The call is intended to fund transnational and interdisciplinary research projects in the field of personalized medicine with clinical relevance. Using information and communication technologies and the (further) development of innovative data solutions, new concepts and approaches are to be researched that can facilitate the implementation of personalized medicine in the clinic. It is (optionally) provided that the knowledge base can also be expanded so that, as in the previous calls, a combination of basic research relevant to the project and clinically oriented research is possible. The integration of research on ethical, legal and social issues related to the project is mandatory; Optionally, relevant health economic questions can also be processed.
The research consortia must include at least 3 partners from 3 participating countries. The projects can be set up for a maximum of 3 years.
Information on the call is available on the ERA PerMed website: http://www.erapermed.eu/joint-calls/joint-transnational-call-2021/
Source: ERAPerMed from 14.12.2020
The new free trade agreement with Great Britain cushions the worst fears of a no-deal, but the trade will be expensive and complex, Spectaris says.
In December 2020, BIO Deutschland published its annual review.